Overview

Autonomic Nervous System and Chronic Fatigue Syndrome

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The investigators propose to test the hypothesis that the sympathetic nervous system contributes to the cardiovascular and inflammatory abnormalities present in the chronic fatigue syndrome (CFS) and, in particular in the subset of patients characterized by postural tachycardia syndrome (POTS). CFS and POTS are seen mostly in otherwise normal young women, and are the cause of significant disability. A substantial proportion of patients referred for evaluation of POTS met diagnostic criteria for CFS and, conversely, a subset of patients referred for treatment for CFS have POTS. The investigators hypothesize that sympathetic activation underlies the pathophysiology of patients in whom CFS and POTS overlap (CFS-P).
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University
Vanderbilt University Medical Center
Treatments:
Methyldopa
omega-N-Methylarginine
Trimethaphan
Trimethaphan camsylate